The pharma wholesale and distribution market is estimated to grow at a CAGR of 5% in the first half of the forecast period. The market is estimated to reach a revenue of $1,447bn in 2025. In 2018, the branded drugs submarket held 78% of the pharma wholesale and distribution market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 217-page report you will receive 135 charts– all unavailable elsewhere.

The 217-page report provides clear detailed insight into the pharma wholesale and distribution market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Download Free Sample Pages of this report

Report Scope
Global Pharma Wholesale and Distribution Market
from 2020-2030

Forecast of the Global Pharma Wholesale and Distribution market by Category:

  • Generic Drugs
  • Branded Drugs
  • Others

This report provides individual revenue forecasts to 2030 for these national markets:

  • US
  • Germany
  • France
  • Italy
  • Spain
  • UK
  • Japan
  • China
  • Brazil
  • India
  • Russia
  • RoW
     

Each National Market is further segmented into generic drugs, branded drugs and others

Our study discusses the selected leading companies that are the major players in the global pharma and wholesale distribution market:

  • Alfresa Holdings
  • AmerisourceBergen
  • Cardinal Health
  • CR Pharmaceuticals
  • CuraScript SD
  • McKesson
  • Medipal Holdings Corporation
  • Morris and Dickson
  • Mutual Drug Company
  • PHOENIX Group
  • Shanghai Fosun Pharmaceuticals
  • Sinopharm
  • Suzuken
  • Walgreens Boots Alliance

This report provides a SWOT and STEP analysis of the pharma wholesale and distribution market.